# Liraglutide (Genetical Recombination) S.C. Injection 18mg (ビクトーザ皮下注１８ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 2499410G1021). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 2499410G1021
- **Product name (Japanese):** ビクトーザ皮下注１８ｍｇ
- **English title:** Liraglutide (Genetical Recombination) S.C. Injection 18mg
- **Active ingredient:** リラグルチド（遺伝子組換え）
- **Active ingredient (INN):** Liraglutide (Genetical Recombination)
- **Strength / unit:** １８ｍｇ３ｍＬ１キット
- **Route:** Injection (注射薬)
- **Therapeutic category:** 24 Hormones (incl. antihormones) (ホルモン剤（抗ホルモン剤を含む）) › 249 Other hormones (その他のホルモン剤)
- **Manufacturer:** Novo Nordisk Pharma (ノボ ノルディスク ファーマ)
- **NHI price (reference only):** JPY 4634 per １８ｍｇ３ｍＬ１キット
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/2499410G1021
- **JSON:** https://www.nifujipharma.com/api/drugs/2499410G1021

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Liraglutide%20(Genetical%20Recombination)%20S.C.%20Injection%2018mg%20(%E3%83%93%E3%82%AF%E3%83%88%E3%83%BC%E3%82%B6%E7%9A%AE%E4%B8%8B%E6%B3%A8%EF%BC%91%EF%BC%98%EF%BD%8D%EF%BD%87)%20%2F%20YJ%202499410G1021#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.